Clinical Trials Logo

Clinical Trial Details — Status: Terminated

Administrative data

NCT number NCT02314598
Other study ID # TEC Study
Secondary ID
Status Terminated
Phase
First received
Last updated
Start date January 2015
Est. completion date September 14, 2017

Study information

Verified date October 2019
Source Medtronic BRC
Contact n/a
Is FDA regulated No
Health authority
Study type Observational

Clinical Trial Summary

This is a prospective, non-randomized, multicenter, post market release study which will collect electrograms (EGMs) from patients at risk of a suspected insulation failure to the high voltage portion of the defibrillator lead and will evaluate the electrogram signals.


Recruitment information / eligibility

Status Terminated
Enrollment 46
Est. completion date September 14, 2017
Est. primary completion date May 16, 2017
Accepts healthy volunteers No
Gender All
Age group 18 Years and older
Eligibility Inclusion Criteria:

- Subject is willing to sign and date the study Informed Consent form

- Subject is at least 18 years of age (or older, if required by local law)

- Subject is willing and able to wear a Holter monitor for up to 24 hours

- Subject has been implanted with a Medtronic ICD or CRT-D device

- Subject has an increased risk of lead insulation breach

Exclusion Criteria:

- Subject has medical conditions that would limit study participation

- Subject is enrolled in one or more concurrent studies that would confound the results of this study

Study Design


Related Conditions & MeSH terms


Intervention

Other:
No treatment


Locations

Country Name City State
Slovakia SUSCCH Banska Bystrica
Slovakia NUSCH Bratislava

Sponsors (1)

Lead Sponsor Collaborator
Medtronic BRC

Country where clinical trial is conducted

Slovakia, 

Outcome

Type Measure Description Time frame Safety issue
Primary Number of Patients With Abnormal Electrograms During a Lead Issue Number of patients with at least one instance of abnormal noise during recording. Electrograms will be collected during 24 hours and afterwards abnormalities in the electrograms will be visually identified. 24 hours
Secondary Proportion of Patients With Abnormal Electrograms and Lead Failure Compare the proportion of patients with abnormal electrograms (e.g. high frequency spike) and a high voltage lead failure within 1 month to those patients with abnormal electrograms and no lead failure within 1 month 1 month
Secondary Additional Abnormal Electrogram Characteristics Identify additional characteristics in the Far-field Electrograms that may halp to identify patients at risk of a high voltage lead failure 1 month